A DMEPOS supplier agrees to pay $29M to resolve False Claims Act allegations that it billed Medicare, MA Plans, and beneficiaries for oxygen equipment for which it had already received payment in full; the FDA releases numerous guidance documents regarding 510(k) submissions, the breakthrough device program, and the biological evaluation of medical devices; a participant in a $3.6M durable medical equipment fraud scheme pleads guilty to utilizing telemedicine companies to generate fraudulent orders for medically unnecessary durable See more +

A DMEPOS supplier agrees to pay $29M to resolve False Claims Act allegations that it billed Medicare, MA Plans, and beneficiaries for oxygen equipment for which it had already received payment in full; the FDA releases numerous guidance documents regarding 510(k) submissions, the breakthrough device program, and the biological evaluation of medical devices; a participant in a $3.6M durable medical equipment fraud scheme pleads guilty to utilizing telemedicine companies to generate fraudulent orders for medically unnecessary durable medical equipment and soliciting and receiving kickbacks. See less -